Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Aug;100(4):814–818. doi: 10.1111/j.1476-5381.1990.tb14097.x

Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus during transient ischaemia.

P Andiné 1, K A Rudolphi 1, B B Fredholm 1, H Hagberg 1
PMCID: PMC1917600  PMID: 2207501

Abstract

1. The adenosine uptake blocker propentofylline (HWA 285) has previously been shown to protect hippocampal CA1 pyramidal cells from ischaemia-induced delayed neuronal death. The influence of propentofylline, on the extracellular concentrations of purines, aspartate and glutamate in the CA1 of the rat hippocampus during transient forebrain ischaemia was investigated. 2. Twenty min of ischaemia was induced by four-vessel occlusion in Wistar rats, extracellular compounds were sampled by use of microdialysis and EEG was recorded by a tungsten electrode attached to the dialysis probe. 3. Propentofylline (10 mg kg-1 i.p.) did not influence the basal levels of any of the compounds in the hippocampal dialysates. 4. The EEG became isoelectric within 20 s after induction of ischaemia. 5. Extracellular adenosine, inosine, hypoxanthine, aspartate and glutamate increased several fold during ischaemia and remained elevated during early reflow. Within 2 h of reperfusion the concentration of all compounds was normalized. Xanthine increased upon reperfusion and remained elevated after 2 h. 6. Propentofylline (10 mg kg-1 i.p.) administered 15 min before ischaemia significantly enhanced the ischaemia-evoked increase of adenosine but attenuated the increases of the other purine catabolites and of glutamate. 7. In separate in vitro experiments, propentofylline did not inhibit adenosine deaminase activity. 8. The present data show that propentofylline enhances extracellular adenosine and lowers extracellular glutamate in vivo during ischaemia. These findings may be important in relation to the neuroprotective properties of propentofylline.

Full text

PDF
814

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashton D., De Prins E., Willems R., Van Belle H., Wauquier A. Anticonvulsant action of the nucleoside transport inhibitor, soluflazine, on synaptic and non-synaptic epileptogenesis in the guinea-pig hippocampus. Epilepsy Res. 1988 Mar-Apr;2(2):65–71. doi: 10.1016/0920-1211(88)90021-6. [DOI] [PubMed] [Google Scholar]
  2. Benveniste H., Drejer J., Schousboe A., Diemer N. H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem. 1984 Nov;43(5):1369–1374. doi: 10.1111/j.1471-4159.1984.tb05396.x. [DOI] [PubMed] [Google Scholar]
  3. Corradetti R., Lo Conte G., Moroni F., Passani M. B., Pepeu G. Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur J Pharmacol. 1984 Sep 3;104(1-2):19–26. doi: 10.1016/0014-2999(84)90364-9. [DOI] [PubMed] [Google Scholar]
  4. DeLeo J., Schubert P., Kreutzberg G. W. Propentofylline (HWA 285) protects hippocampal neurons of Mongolian gerbils against ischemic damage in the presence of an adenosine antagonist. Neurosci Lett. 1988 Feb 3;84(3):307–311. doi: 10.1016/0304-3940(88)90526-5. [DOI] [PubMed] [Google Scholar]
  5. DeLeo J., Schubert P., Kreutzberg G. W. Protection against ischemic brain damage using propentofylline in gerbils. Stroke. 1988 Dec;19(12):1535–1539. doi: 10.1161/01.str.19.12.1535. [DOI] [PubMed] [Google Scholar]
  6. DeLeo J., Toth L., Schubert P., Rudolphi K., Kreutzberg G. W. Ischemia-induced neuronal cell death, calcium accumulation, and glial response in the hippocampus of the Mongolian gerbil and protection by propentofylline (HWA 285). J Cereb Blood Flow Metab. 1987 Dec;7(6):745–751. doi: 10.1038/jcbfm.1987.129. [DOI] [PubMed] [Google Scholar]
  7. Deckert J., Bisserbe J. C., Klein E., Marangos P. J. Adenosine uptake sites in brain: regional distribution of putative subtypes in relationship to adenosine A1-receptors. J Neurosci. 1988 Jul;8(7):2338–2349. doi: 10.1523/JNEUROSCI.08-07-02338.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Deckert J., Bisserbe J. C., Marangos P. J. Quantitative [3H]dipyridamole autoradiography: evidence for adenosine transporter heterogeneity in guinea pig brain. Naunyn Schmiedebergs Arch Pharmacol. 1987 Jun;335(6):660–666. doi: 10.1007/BF00166983. [DOI] [PubMed] [Google Scholar]
  9. Dolphin A. C., Archer E. R. An adenosine agonist inhibits and a cyclic AMP analogue enhances the release of glutamate but not GABA from slices of rat dentate gyrus. Neurosci Lett. 1983 Dec 23;43(1):49–54. doi: 10.1016/0304-3940(83)90127-1. [DOI] [PubMed] [Google Scholar]
  10. Dragunow M., Faull R. L. Neuroprotective effects of adenosine. Trends Pharmacol Sci. 1988 Jun;9(6):193–194. doi: 10.1016/0165-6147(88)90079-x. [DOI] [PubMed] [Google Scholar]
  11. Evans M. C., Swan J. H., Meldrum B. S. An adenosine analogue, 2-chloroadenosine, protects against long term development of ischaemic cell loss in the rat hippocampus. Neurosci Lett. 1987 Dec 29;83(3):287–292. doi: 10.1016/0304-3940(87)90101-7. [DOI] [PubMed] [Google Scholar]
  12. Fastbom J., Fredholm B. B. Inhibition of [3H] glutamate release from rat hippocampal slices by L-phenylisopropyladenosine. Acta Physiol Scand. 1985 Sep;125(1):121–123. doi: 10.1111/j.1748-1716.1985.tb07698.x. [DOI] [PubMed] [Google Scholar]
  13. Fredholm B. B., Hedqvist P., Vernet L. Effect of theophylline and other drugs on rabbit renal cyclic nucleotide phosphodiesterase, 5'-nucleotidase and adenosine deaminase. Biochem Pharmacol. 1978;27(24):2845–2850. doi: 10.1016/0006-2952(78)90199-5. [DOI] [PubMed] [Google Scholar]
  14. Fredholm B. B., Lindström K. The xanthine derivative 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine (HWA 285) enhances the actions of adenosine. Acta Pharmacol Toxicol (Copenh) 1986 Mar;58(3):187–192. doi: 10.1111/j.1600-0773.1986.tb00093.x. [DOI] [PubMed] [Google Scholar]
  15. Fredholm B. B., Sollevi A. Cardiovascular effects of adenosine. Clin Physiol. 1986 Feb;6(1):1–21. doi: 10.1111/j.1475-097x.1986.tb00139.x. [DOI] [PubMed] [Google Scholar]
  16. Hagberg H., Andersson P., Lacarewicz J., Jacobson I., Butcher S., Sandberg M. Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J Neurochem. 1987 Jul;49(1):227–231. doi: 10.1111/j.1471-4159.1987.tb03419.x. [DOI] [PubMed] [Google Scholar]
  17. Hagberg H., Lehmann A., Sandberg M., Nyström B., Jacobson I., Hamberger A. Ischemia-induced shift of inhibitory and excitatory amino acids from intra- to extracellular compartments. J Cereb Blood Flow Metab. 1985 Sep;5(3):413–419. doi: 10.1038/jcbfm.1985.56. [DOI] [PubMed] [Google Scholar]
  18. Jørgensen M. B., Diemer N. H. Selective neuron loss after cerebral ischemia in the rat: possible role of transmitter glutamate. Acta Neurol Scand. 1982 Nov;66(5):536–546. doi: 10.1111/j.1600-0404.1982.tb03140.x. [DOI] [PubMed] [Google Scholar]
  19. Kalaria R. N., Harik S. I. Adenosine receptors and the nucleoside transporter in human brain vasculature. J Cereb Blood Flow Metab. 1988 Feb;8(1):32–39. doi: 10.1038/jcbfm.1988.5. [DOI] [PubMed] [Google Scholar]
  20. Kalaria R. N., Harik S. I. Nucleoside transporter of cerebral microvessels and choroid plexus. J Neurochem. 1986 Dec;47(6):1849–1856. doi: 10.1111/j.1471-4159.1986.tb13098.x. [DOI] [PubMed] [Google Scholar]
  21. Marangos P. J., Houston M., Montgomery P. [3H]dipyridamole: a new ligand probe for brain adenosine uptake sites. Eur J Pharmacol. 1985 Nov 19;117(3):393–394. doi: 10.1016/0014-2999(85)90017-2. [DOI] [PubMed] [Google Scholar]
  22. Nagata K., Ogawa T., Omosu M., Fujimoto K., Hayashi S. In vitro and in vivo inhibitory effects of propentofylline on cyclic AMP phosphodiesterase activity. Arzneimittelforschung. 1985;35(7):1034–1036. [PubMed] [Google Scholar]
  23. Nagy J. I., Geiger J. D., Daddona P. E. Adenosine uptake sites in rat brain: identification using [3H]nitrobenzylthioinosine and co-localization with adenosine deaminase. Neurosci Lett. 1985 Mar 22;55(1):47–53. doi: 10.1016/0304-3940(85)90310-6. [DOI] [PubMed] [Google Scholar]
  24. Phillis J. W., O'Regan M. H., Walter G. A. Effects of two nucleoside transport inhibitors, dipyridamole and soluflazine, on purine release from the rat cerebral cortex. Brain Res. 1989 Mar 6;481(2):309–316. doi: 10.1016/0006-8993(89)90808-1. [DOI] [PubMed] [Google Scholar]
  25. Phillis J. W., Wu P. H. The effect of various centrally active drugs on adenosine uptake by the central nervous system. Comp Biochem Physiol C. 1982;72(2):179–187. doi: 10.1016/0306-4492(82)90082-x. [DOI] [PubMed] [Google Scholar]
  26. Pulsinelli W. A., Brierley J. B. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke. 1979 May-Jun;10(3):267–272. doi: 10.1161/01.str.10.3.267. [DOI] [PubMed] [Google Scholar]
  27. Rudolphi K. A., Keil M., Hinze H. J. Effect of theophylline on ischemically induced hippocampal damage in Mongolian gerbils: a behavioral and histopathological study. J Cereb Blood Flow Metab. 1987 Feb;7(1):74–81. doi: 10.1038/jcbfm.1987.11. [DOI] [PubMed] [Google Scholar]
  28. Sandberg M., Butcher S. P., Hagberg H. Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: in vivo dialysis of the rat hippocampus. J Neurochem. 1986 Jul;47(1):178–184. doi: 10.1111/j.1471-4159.1986.tb02847.x. [DOI] [PubMed] [Google Scholar]
  29. Seiffge D., Kremer E. Effects of propentofylline (HWA 285) on laser-induced thrombus formation in healthy and diseased rat mesenteric arterioles. Curr Med Res Opin. 1986;10(2):94–98. doi: 10.1185/03007998609110425. [DOI] [PubMed] [Google Scholar]
  30. Sollevi A. Cardiovascular effects of adenosine in man; possible clinical implications. Prog Neurobiol. 1986;27(4):319–349. doi: 10.1016/0301-0082(86)90005-5. [DOI] [PubMed] [Google Scholar]
  31. Stefanovich V. Uptake of adenosine by isolated bovine cortex microvessels. Neurochem Res. 1983 Nov;8(11):1459–1469. doi: 10.1007/BF00965001. [DOI] [PubMed] [Google Scholar]
  32. Swan J. H., Evans M. C., Meldrum B. S. Long-term development of selective neuronal loss and the mechanism of protection by 2-amino-7-phosphonoheptanoate in a rat model of incomplete forebrain ischaemia. J Cereb Blood Flow Metab. 1988 Feb;8(1):64–78. doi: 10.1038/jcbfm.1988.9. [DOI] [PubMed] [Google Scholar]
  33. Wauquier A., Van Belle H., Van den Broeck W. A., Janssen P. A. Sleep improvement in dogs after oral administration of mioflazine, a nucleoside transport inhibitor. Psychopharmacology (Berl) 1987;91(4):434–439. doi: 10.1007/BF00216007. [DOI] [PubMed] [Google Scholar]
  34. Wieloch T., Lindvall O., Blomqvist P., Gage F. H. Evidence for amelioration of ischaemic neuronal damage in the hippocampal formation by lesions of the perforant path. Neurol Res. 1985 Mar;7(1):24–26. doi: 10.1080/01616412.1985.11739695. [DOI] [PubMed] [Google Scholar]
  35. Zetterström T., Vernet L., Ungerstedt U., Tossman U., Jonzon B., Fredholm B. B. Purine levels in the intact rat brain. Studies with an implanted perfused hollow fibre. Neurosci Lett. 1982 Apr 16;29(2):111–115. doi: 10.1016/0304-3940(82)90338-x. [DOI] [PubMed] [Google Scholar]
  36. von Lubitz D. K., Dambrosia J. M., Kempski O., Redmond D. J. Cyclohexyl adenosine protects against neuronal death following ischemia in the CA1 region of gerbil hippocampus. Stroke. 1988 Sep;19(9):1133–1139. doi: 10.1161/01.str.19.9.1133. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES